以 HPO 交叉檢視

HPO → 對應的病歷用詞，並附加具此 HPO 的疾病作為參考。

搜尋 HPO

Muscle weakness

HP:0001324

對應病歷用詞(0)

尚無對應用詞。

具此 HPO 的疾病（附加參考）(250)

Andersen-Tawil syndromeORPHA:37553 · Obligate (100%)
Steinert myotonic dystrophyORPHA:273 · Obligate (100%)
3-methylglutaconic aciduria type 9ORPHA:505216 · Very frequent (99-80%)
Acute adrenal insufficiencyORPHA:95409 · Very frequent (99-80%)
Addison diseaseORPHA:85138 · Very frequent (99-80%)
Adrenocortical carcinoma with pure aldosterone hypersecretionORPHA:231625 · Very frequent (99-80%)
Adult intestinal botulismORPHA:178487 · Very frequent (99-80%)
Adult polyglucosan body diseaseORPHA:206583 · Very frequent (99-80%)
Alpha-N-acetylgalactosaminidase deficiency type 1ORPHA:79279 · Very frequent (99-80%)
Antisynthetase syndromeORPHA:81 · Very frequent (99-80%)
ArachnoiditisORPHA:137817 · Very frequent (99-80%)
Ataxia with vitamin E deficiencyORPHA:96 · Very frequent (99-80%)
AthyreosisORPHA:95713 · Very frequent (99-80%)
Bethlem muscular dystrophyORPHA:610 · Very frequent (99-80%)
Carnitine palmitoyltransferase II deficiencyORPHA:157 · Very frequent (99-80%)
Carnitine-acylcarnitine translocase deficiencyORPHA:159 · Very frequent (99-80%)
Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndromeORPHA:1171 · Very frequent (99-80%)
Charcot-Marie-Tooth disease type 1BORPHA:101082 · Very frequent (99-80%)
Cold agglutinin diseaseORPHA:56425 · Very frequent (99-80%)
Cryoglobulinemic vasculitisORPHA:91138 · Very frequent (99-80%)
CystinosisORPHA:213 · Very frequent (99-80%)
Drug-induced autoimmune hemolytic anemiaORPHA:90037 · Very frequent (99-80%)
Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndromeORPHA:496641 · Very frequent (99-80%)
Episodic ataxia type 7ORPHA:209970 · Very frequent (99-80%)
Episodic ataxia with slurred speechORPHA:401953 · Very frequent (99-80%)
Facial onset sensory and motor neuronopathyORPHA:85162 · Very frequent (99-80%)
Familial or sporadic hemiplegic migraineORPHA:569 · Very frequent (99-80%)
Foodborne botulismORPHA:228371 · Very frequent (99-80%)
Genetic recurrent myoglobinuriaORPHA:99845 · Very frequent (99-80%)
Glycogen storage disease due to acid maltase deficiencyORPHA:365 · Very frequent (99-80%)
Glycogen storage disease due to acid maltase deficiency, infantile onsetORPHA:308552 · Very frequent (99-80%)
Hereditary sensory and autonomic neuropathy type 1ORPHA:36386 · Very frequent (99-80%)
Hypocalcemic vitamin D-dependent ricketsORPHA:289157 · Very frequent (99-80%)
Iatrogenic botulismORPHA:254509 · Very frequent (99-80%)
Inhalational botulismORPHA:254504 · Very frequent (99-80%)
Isolated complex I deficiencyORPHA:2609 · Very frequent (99-80%)
Juvenile amyotrophic lateral sclerosisORPHA:300605 · Very frequent (99-80%)
Juvenile dermatomyositisORPHA:93672 · Very frequent (99-80%)
Juvenile primary lateral sclerosisORPHA:247604 · Very frequent (99-80%)
Laminin subunit alpha 2-related congenital muscular dystrophyORPHA:258 · Very frequent (99-80%)
Late-onset isolated ACTH deficiencyORPHA:199299 · Very frequent (99-80%)
Lethal ataxia with deafness and optic atrophyORPHA:1187 · Very frequent (99-80%)
MELASORPHA:550 · Very frequent (99-80%)
Mitochondrial DNA-related cardiomyopathy and hearing lossORPHA:1349 · Very frequent (99-80%)
Mitochondrial membrane protein-associated neurodegenerationORPHA:289560 · Very frequent (99-80%)
Mitochondrial myopathy with reversible cytochrome C oxidase deficiencyORPHA:254864 · Very frequent (99-80%)
Mixed-type autoimmune hemolytic anemiaORPHA:90036 · Very frequent (99-80%)
Monomelic amyotrophyORPHA:65684 · Very frequent (99-80%)
Muscular pseudohypertrophy-hypothyroidism syndromeORPHA:2349 · Very frequent (99-80%)
Musculocontractural Ehlers-Danlos syndromeORPHA:2953 · Very frequent (99-80%)
Myasthenia gravisORPHA:589 · Very frequent (99-80%)
Native American myopathyORPHA:168572 · Very frequent (99-80%)
Noonan syndromeORPHA:648 · Very frequent (99-80%)
Oncogenic osteomalaciaORPHA:352540 · Very frequent (99-80%)
PoliomyelitisORPHA:2912 · Very frequent (99-80%)
Polyneuropathy-intellectual disability-acromicria-premature menopause syndromeORPHA:2928 · Very frequent (99-80%)
Pontocerebellar hypoplasia type 1ORPHA:2254 · Very frequent (99-80%)
Postpoliomyelitis syndromeORPHA:2942 · Very frequent (99-80%)
Spastic paraplegia type 2ORPHA:99015 · Very frequent (99-80%)
Spinocerebellar ataxia type 18ORPHA:98771 · Very frequent (99-80%)
Subacute inflammatory demyelinating polyneuropathyORPHA:206594 · Very frequent (99-80%)
Systemic primary carnitine deficiencyORPHA:158 · Very frequent (99-80%)
Tay-Sachs diseaseORPHA:845 · Very frequent (99-80%)
Thyroid ectopiaORPHA:95712 · Very frequent (99-80%)
TK2-related mitochondrial DNA maintenance defect, myopathic formORPHA:254875 · Very frequent (99-80%)
Toxin-mediated infectious botulismORPHA:230800 · Very frequent (99-80%)
Walker-Warburg syndromeORPHA:899 · Very frequent (99-80%)
Wound botulismORPHA:178475 · Very frequent (99-80%)
X-linked Charcot-Marie-Tooth disease type 5ORPHA:99014 · Very frequent (99-80%)
X-linked sideroblastic anemiaORPHA:75563 · Very frequent (99-80%)
Acute panmyelosis with myelofibrosisORPHA:86843 · Frequent (79-30%)
Acute promyelocytic leukemiaORPHA:520 · Frequent (79-30%)
Acute radiation syndromeORPHA:454831 · Frequent (79-30%)
Acute transverse myelitisORPHA:139417 · Frequent (79-30%)
Adrenocortical carcinomaORPHA:1501 · Frequent (79-30%)
Adult-onset autosomal dominant leukodystrophyORPHA:99027 · Frequent (79-30%)
African trypanosomiasisORPHA:3385 · Frequent (79-30%)
Ahmad syndromeORPHA:85274 · Frequent (79-30%)
Atypical teratoid rhabdoid tumorORPHA:99966 · Frequent (79-30%)
Autosomal dominant hypophosphatemic ricketsORPHA:89937 · Frequent (79-30%)
Autosomal recessive cerebelloparenchymal disorder type 3ORPHA:1170 · Frequent (79-30%)
Autosomal recessive spastic ataxia of Charlevoix-SaguenayORPHA:98 · Frequent (79-30%)
Autosomal recessive spastic paraplegia type 26ORPHA:101006 · Frequent (79-30%)
Autosomal recessive spastic paraplegia type 9BORPHA:447760 · Frequent (79-30%)
Barth syndromeORPHA:111 · Frequent (79-30%)
Bartter syndrome type 4ORPHA:89938 · Frequent (79-30%)
Becker muscular dystrophyORPHA:98895 · Frequent (79-30%)
Beta-thalassemiaORPHA:848 · Frequent (79-30%)
Camurati-Engelmann diseaseORPHA:1328 · Frequent (79-30%)
Carnitine palmitoyl transferase II deficiency, myopathic formORPHA:228302 · Frequent (79-30%)
Carnitine palmitoyl transferase II deficiency, severe infantile formORPHA:228305 · Frequent (79-30%)
CholeraORPHA:173 · Frequent (79-30%)
Classical Ehlers-Danlos syndromeORPHA:287 · Frequent (79-30%)
Classical-like Ehlers-Danlos syndrome type 1ORPHA:230839 · Frequent (79-30%)
Combined oxidative phosphorylation defect type 13ORPHA:319514 · Frequent (79-30%)
Congenital glucokinase-related hyperinsulinismORPHA:79299 · Frequent (79-30%)
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean typeORPHA:70472 · Frequent (79-30%)
Congenital multicore myopathy with external ophthalmoplegiaORPHA:98905 · Frequent (79-30%)
Cushing diseaseORPHA:96253 · Frequent (79-30%)
Cushing syndrome due to ectopic ACTH secretionORPHA:99889 · Frequent (79-30%)
Danon diseaseORPHA:34587 · Frequent (79-30%)
DEND syndromeORPHA:79134 · Frequent (79-30%)
Diffuse cutaneous systemic sclerosisORPHA:220393 · Frequent (79-30%)
Distal renal tubular acidosisORPHA:18 · Frequent (79-30%)
Dopa-responsive dystonia due to sepiapterin reductase deficiencyORPHA:70594 · Frequent (79-30%)
DPM3-CDGORPHA:263494 · Frequent (79-30%)
Eisenmenger syndromeORPHA:97214 · Frequent (79-30%)
Evans syndromeORPHA:1959 · Frequent (79-30%)
Familial cerebral cavernous malformationORPHA:221061 · Frequent (79-30%)
Familial isolated hypoparathyroidismORPHA:2238 · Frequent (79-30%)
Fragile X-associated tremor/ataxia syndromeORPHA:93256 · Frequent (79-30%)
Friedreich ataxiaORPHA:95 · Frequent (79-30%)
Gitelman syndromeORPHA:358 · Frequent (79-30%)
GlioblastomaORPHA:360 · Frequent (79-30%)
Glycogen storage disease due to aldolase A deficiencyORPHA:57 · Frequent (79-30%)
Glycogen storage disease due to muscle phosphofructokinase deficiencyORPHA:371 · Frequent (79-30%)
Glycogen storage disease due to phosphoglycerate kinase 1 deficiencyORPHA:713 · Frequent (79-30%)
Hemorrhagic fever-renal syndromeORPHA:340 · Frequent (79-30%)
Hereditary neuropathy with liability to pressure palsiesORPHA:640 · Frequent (79-30%)
Hereditary spherocytosisORPHA:822 · Frequent (79-30%)
HJV or HAMP-related hemochromatosisORPHA:79230 · Frequent (79-30%)
HoloprosencephalyORPHA:2162 · Frequent (79-30%)
Immune-mediated thrombotic thrombocytopenic purpuraORPHA:93585 · Frequent (79-30%)
Inherited Creutzfeldt-Jakob diseaseORPHA:282166 · Frequent (79-30%)
Intellectual disability-muscle weakness-short stature-facial dysmorphism syndromeORPHA:457365 · Frequent (79-30%)
Isolated ATP synthase deficiencyORPHA:254913 · Frequent (79-30%)
Kjellin syndromeORPHA:100996 · Frequent (79-30%)
Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiencyORPHA:300179 · Frequent (79-30%)
Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiencyORPHA:1900 · Frequent (79-30%)
L-Arginine:glycine amidinotransferase deficiencyORPHA:35704 · Frequent (79-30%)
Lassa feverORPHA:99824 · Frequent (79-30%)
Leukoencephalopathy-palmoplantar keratoderma syndromeORPHA:2386 · Frequent (79-30%)
Liddle syndromeORPHA:526 · Frequent (79-30%)
Lymphedema-distichiasis syndromeORPHA:33001 · Frequent (79-30%)
Menkes diseaseORPHA:565 · Frequent (79-30%)
Metachromatic leukodystrophyORPHA:512 · Frequent (79-30%)
Metachromatic leukodystrophy, adult formORPHA:309271 · Frequent (79-30%)
Metachromatic leukodystrophy, juvenile formORPHA:309263 · Frequent (79-30%)
Metachromatic leukodystrophy, late infantile formORPHA:309256 · Frequent (79-30%)
MFF-related encephalopathy due to mitochondrial and peroxisomal fission defectORPHA:485421 · Frequent (79-30%)
Mitochondrial DNA-associated Leigh syndromeORPHA:255210 · Frequent (79-30%)
Mitochondrial trifunctional protein deficiencyORPHA:746 · Frequent (79-30%)
Multiple mitochondrial dysfunctions syndrome type 3ORPHA:363424 · Frequent (79-30%)
Oculodentodigital dysplasiaORPHA:2710 · Frequent (79-30%)
POEMS syndromeORPHA:2905 · Frequent (79-30%)
Porphyria due to ALA dehydratase deficiencyORPHA:100924 · Frequent (79-30%)
Postsynaptic congenital myasthenic syndromeORPHA:98913 · Frequent (79-30%)
Primary Fanconi renotubular syndromeORPHA:3337 · Frequent (79-30%)
Progressive pseudorheumatoid dysplasiaORPHA:1159 · Frequent (79-30%)
Q feverORPHA:781 · Frequent (79-30%)
Riboflavin transporter deficiencyORPHA:97229 · Frequent (79-30%)
Sandhoff diseaseORPHA:796 · Frequent (79-30%)
Sialidosis type 1ORPHA:812 · Frequent (79-30%)
Sneddon syndromeORPHA:820 · Frequent (79-30%)
Spinal fast-flow vascular malformationORPHA:715025 · Frequent (79-30%)
Spinocerebellar ataxia type 7ORPHA:94147 · Frequent (79-30%)
Sub-cortical nodular heterotopiaORPHA:101029 · Frequent (79-30%)
Systemic sclerosisORPHA:90291 · Frequent (79-30%)
Takayasu arteritisORPHA:3287 · Frequent (79-30%)
Thoracic outlet syndromeORPHA:97330 · Frequent (79-30%)
TrichinellosisORPHA:863 · Frequent (79-30%)
Ullrich congenital muscular dystrophyORPHA:75840 · Frequent (79-30%)
Variegate porphyriaORPHA:79473 · Frequent (79-30%)
WARS2-related combined oxidative phosphorylation defectORPHA:572798 · Frequent (79-30%)
X-linked complicated corpus callosum dysgenesisORPHA:1497 · Frequent (79-30%)
X-linked intellectual disability-hypogammaglobulinemia-progressive neurological deterioration syndromeORPHA:85317 · Frequent (79-30%)
Acute disseminated encephalomyelitisORPHA:83597 · Occasional (29-5%)
Alexander diseaseORPHA:58 · Occasional (29-5%)
AngiostrongyliasisORPHA:74 · Occasional (29-5%)
Argininosuccinic aciduriaORPHA:23 · Occasional (29-5%)
Arnold-Chiari malformation type IORPHA:268882 · Occasional (29-5%)
Autosomal dominant hyperinsulinism due to Kir6.2 deficiencyORPHA:276580 · Occasional (29-5%)
Autosomal dominant spastic paraplegia type 9AORPHA:447753 · Occasional (29-5%)
Bannayan-Riley-Ruvalcaba syndromeORPHA:109 · Occasional (29-5%)
Carney complexORPHA:1359 · Occasional (29-5%)
Chédiak-Higashi syndromeORPHA:167 · Occasional (29-5%)
Chronic graft versus host diseaseORPHA:99921 · Occasional (29-5%)
CLN12 diseaseORPHA:314632 · Occasional (29-5%)
Coffin-Lowry syndromeORPHA:192 · Occasional (29-5%)
Combined oxidative phosphorylation defect type 39ORPHA:565624 · Occasional (29-5%)
Congenital Gerbode defectORPHA:99095 · Occasional (29-5%)
Dural sinus malformation with arteriovenous shuntORPHA:97339 · Occasional (29-5%)
Ectopic aldosterone-producing tumorORPHA:231632 · Occasional (29-5%)
Exercise-induced malignant hyperthermiaORPHA:466650 · Occasional (29-5%)
Familial hyperaldosteronism type IORPHA:403 · Occasional (29-5%)
Familial hyperaldosteronism type IIORPHA:404 · Occasional (29-5%)
Familial hyperaldosteronism type IIIORPHA:251274 · Occasional (29-5%)
Focal myositisORPHA:48918 · Occasional (29-5%)
Full schwannomatosisORPHA:93921 · Occasional (29-5%)
Giant cell arteritisORPHA:397 · Occasional (29-5%)
Glycogen storage disease due to muscle glycogen phosphorylase deficiencyORPHA:368 · Occasional (29-5%)
Glycogen storage disease due to phosphoglycerate mutase deficiencyORPHA:97234 · Occasional (29-5%)
GMPPB-related limb-girdle muscular dystrophy R19ORPHA:363623 · Occasional (29-5%)
GNE myopathyORPHA:602 · Occasional (29-5%)
Hereditary ATTR amyloidosisORPHA:271861 · Occasional (29-5%)
Hyperparathyroidism-jaw tumor syndromeORPHA:99880 · Occasional (29-5%)
HypophosphatasiaORPHA:436 · Occasional (29-5%)
Idiopathic hypereosinophilic syndromeORPHA:3260 · Occasional (29-5%)
Immunoglobulin A vasculitisORPHA:761 · Occasional (29-5%)
Infantile Krabbe diseaseORPHA:206436 · Occasional (29-5%)
Kallmann syndromeORPHA:478 · Occasional (29-5%)
Kearns-Sayre syndromeORPHA:480 · Occasional (29-5%)
Krabbe diseaseORPHA:487 · Occasional (29-5%)
Kyphoscoliotic Ehlers-Danlos syndromeORPHA:536545 · Occasional (29-5%)
Legionnaires diseaseORPHA:549 · Occasional (29-5%)
Leigh syndromeORPHA:506 · Occasional (29-5%)
LeprosyORPHA:548 · Occasional (29-5%)
Lujo hemorrhagic feverORPHA:319213 · Occasional (29-5%)
Lyme diseaseORPHA:91546 · Occasional (29-5%)
MEPAN syndromeORPHA:508093 · Occasional (29-5%)
Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndromeORPHA:280679 · Occasional (29-5%)
Multicentric reticulohistiocytosisORPHA:139436 · Occasional (29-5%)
Multiple endocrine neoplasia type 2ORPHA:653 · Occasional (29-5%)
Myotonia permanensORPHA:99735 · Occasional (29-5%)
Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndromeORPHA:453499 · Occasional (29-5%)
Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to 9q21.3 microdeletionORPHA:352665 · Occasional (29-5%)
Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to a point mutationORPHA:453504 · Occasional (29-5%)
Neurogenic thoracic outlet syndromeORPHA:100073 · Occasional (29-5%)
Nijmegen breakage syndromeORPHA:647 · Occasional (29-5%)
Norrie diseaseORPHA:649 · Occasional (29-5%)
Parathyroid carcinomaORPHA:143 · Occasional (29-5%)
Pediatric systemic lupus erythematosusORPHA:93552 · Occasional (29-5%)
PellagraORPHA:97352 · Occasional (29-5%)
Postorgasmic illness syndromeORPHA:279947 · Occasional (29-5%)
Primary Sjögren diseaseORPHA:289390 · Occasional (29-5%)
Primary unilateral adrenal hyperplasiaORPHA:231580 · Occasional (29-5%)
Pseudohypoaldosteronism type 2ORPHA:757 · Occasional (29-5%)
Pyle diseaseORPHA:3005 · Occasional (29-5%)
Rift valley feverORPHA:319251 · Occasional (29-5%)
S-adenosylhomocysteine hydrolase deficiencyORPHA:88618 · Occasional (29-5%)
Schilder diseaseORPHA:59298 · Occasional (29-5%)
Schimke immuno-osseous dysplasiaORPHA:1830 · Occasional (29-5%)
Schwartz-Jampel syndromeORPHA:800 · Occasional (29-5%)
Sheehan syndromeORPHA:91355 · Occasional (29-5%)
Sialidosis type 2ORPHA:87876 · Occasional (29-5%)
Stiff skin syndromeORPHA:2833 · Occasional (29-5%)
Susac syndromeORPHA:838 · Occasional (29-5%)
Symptomatic form of HFE-related hemochromatosisORPHA:465508 · Occasional (29-5%)
Synaptic congenital myasthenic syndromeORPHA:98915 · Occasional (29-5%)
ThymomaORPHA:99867 · Occasional (29-5%)
Whipple diseaseORPHA:3452 · Occasional (29-5%)
Wolcott-Rallison syndromeORPHA:1667 · Occasional (29-5%)
X-linked hypophosphatemiaORPHA:89936 · Occasional (29-5%)
Bronchogenic cystORPHA:2357 · Very rare (<4-1%)
Dilated cardiomyopathy with ataxiaORPHA:66634 · Very rare (<4-1%)
Isaacs syndromeORPHA:84142 · Very rare (<4-1%)
Multiple epiphyseal dysplasia due to collagen 9 anomalyORPHA:166002 · Very rare (<4-1%)
PlagueORPHA:707 · Very rare (<4-1%)
Autosomal recessive hypophosphatemic ricketsORPHA:289176 · Excluded (0%)
Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndromeORPHA:330054 · Excluded (0%)